ADAPTIVE BIOTECHNOLOGIES (ADPT) Earnings History & Surprises

NASDAQ:ADPTUS00650F1093

Current stock price

14.21 USD
+0.06 (+0.42%)
Last:

ADPT Earnings overview

Past quarterly earnings results for ADAPTIVE BIOTECHNOLOGIES (ADPT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
Apr 29, 2026
Period
Q1 / 2026
EPS Estimate
-$0.16
Revenue Estimate
61.921M

Last Reported

Most Recent
Release Date
Feb 5, 2026
Period
Q4 / 2025
EPS Reported
-$0.09
EPS Surprise
51.32%
Revenue Surprise
18.33%

Beat Rate

Last 8 Quarters
100%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.09 -0.18 51.32% 60.87% 71.681M 60.579M 18.33% 51.04%
Q3 2025 0.06 -0.15 140.22% 127.27% 93.973M 65.936M 42.52% 102.38%
Q2 2025 -0.17 -0.24 30.19% 45.16% 58.879M 50.388M 16.85% 36.33%
Q1 2025 -0.20 -0.30 32.96% 39.39% 52.443M 43.532M 20.47% 25.24%
Q4 2024 -0.23 -0.26 12.00% 23.33% 47.459M 46.955M 1.07% 3.66%
Q3 2024 -0.22 -0.29 24.98% 37.14% 46.435M 41.012M 13.22% 22.46%
Q2 2024 -0.31 -0.34 8.94% 6.06% 43.19M 39.438M 9.51% -11.72%
Q1 2024 -0.33 -0.35 5.24% 17.50% 41.873M 39.56M 5.85% 11.23%
Q4 2023 -0.30 -0.34 11.21% -7.14% 45.784M 49.427M -7.37% -17.06%
Q3 2023 -0.35 -0.35 -1.25% -9.37% 37.919M 43.822M -13.47% -20.72%
Q2 2023 -0.33 -0.35 6.66% 10.81% 48.926M 45.785M 6.86% 12.06%
Q1 2023 -0.40 -0.38 -4.08% 9.09% 37.647M 37.547M 0.27% -2.52%
Q4 2022 -0.28 -0.35 20.75% 34.88% 55.2M 55.8M -1.08% 45.53%
Q3 2022 -0.32 -0.38 16.56% 20.00% 47.83M 48.991M -2.37% 21.18%
Q2 2022 -0.37 -0.44 15.64% -5.71% 43.66M 43.004M 1.53% 13.37%
Q1 2022 -0.44 -0.47 5.93% -51.72% 38.62M 38.464M 0.41% 0.47%
Q4 2021 -0.43 -0.46 6.61% -30.30% 37.93M 37.437M 1.32% 25.64%
Q3 2021 -0.40 -0.43 6.91% -48.15% 39.47M 37.368M 5.63% 50.08%
Q2 2021 -0.35 -0.44 19.67% -34.62% 38.51M 31.887M 20.77% 83.47%
Q1 2021 -0.29 -0.42 30.41% -16.00% 38.44M 28.302M 35.82% 83.84%
Q4 2020 -0.33 -0.30 -10.47% - 30.19M 27.44M 10.02% -
Q3 2020 -0.27 -0.29 6.89% - 26.3M 24.055M 9.33% -
Q2 2020 -0.26 -0.29 10.56% - 20.99M 19.176M 9.46% -
Q1 2020 -0.25 -0.21 -19.85% - 20.91M 21.958M -4.77% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

ADPT EPS Q2Q GrowthADPT EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 Q1/28 Q3/28 0 100 -100 -200 -300

Revenue Historical Q2Q growth and Acceleration

ADPT Revenue Q2Q GrowthADPT Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 Q1/28 Q3/28 0 20 -20 40 60 80 100

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
63.67%
Max EPS beat (4)
140.22%
Min EPS beat (4)
30.19%

Revenue beat statistics

Revenue beat (4)
4
Average Revenue beat (4)
24.54%
Max Revenue beat (4)
42.52%
Min Revenue beat (4)
16.85%

Analysis

In the last 4 quarters, ADPT has consistently beaten EPS estimates in all releases
ADPT has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, ADPT has beaten the EPS estimates by 63.7% on average.
In the last 4 quarters, ADPT has beaten the revenue estimates by 24.5% on average.

ADAPTIVE BIOTECHNOLOGIES / ADPT Earnings FAQ

Can you provide the last earnings date for ADAPTIVE BIOTECHNOLOGIES?

ADAPTIVE BIOTECHNOLOGIES (ADPT) last reported earnings on 2/5/2026.

Did ADPT stock beat earnings estimates in the most recent quarter?

ADAPTIVE BIOTECHNOLOGIES (ADPT) beat EPS estimates and beat revenue estimates in the most recent quarter.

Can you provide information on how often ADAPTIVE BIOTECHNOLOGIES beats earnings estimates?

In the last 4 quarters, ADAPTIVE BIOTECHNOLOGIES (ADPT) has beaten EPS estimates in 4 out of 4 releases.